Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · CIOC 2027

Pituitary Tumors at CIOC 2027

Part of the CIOC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Pituitary Tumors Session

Pituitary tumors, though typically benign, can cause significant health issues by disrupting hormone production. Research in this field focuses on understanding the genetic and molecular mechanisms driving tumor formation and growth. Scientists explore targeted therapies to shrink tumors without harming healthy tissue, aiming to improve patient outcomes and quality of life. Advanced imaging techniques aid in early detection and precise tumor localization, guiding treatment strategies. Additionally, investigations into hormone replacement therapies help manage the hormonal imbalances resulting from pituitary dysfunction. Collaborative efforts among clinicians, researchers, and patients are crucial for advancing treatment options and enhancing our understanding of pituitary tumor biology. By unraveling the complexities of these tumors, researchers strive to develop personalized approaches tailored to each patient's unique needs, ultimately offering hope for better prognosis and improved survival rates.

Topics Covered in Pituitary Tumors

Topic 01

Prolactinomas

Topic 02

Acromegaly

Topic 03

Nonfunctioning Adenomas

Topic 04

Transsphenoidal Surgery

Topic 05

Dopamine Agonists

Topic 06

Hormone Replacement

Related Scientific Sessions at CIOC 2027

Why Attend the Pituitary Tumors Conference 2027

Earn CPD Credit

Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.

Present Your Research

Oral and poster slots for original Pituitary Tumors work, reviewed by the scientific committee.

Network Globally

Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Pituitary Tumors research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join CIOC 2027 for the Pituitary Tumors track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Pituitary Tumors Conference 2027 — FAQs

What is the Pituitary Tumors track at CIOC 2027?

The Pituitary Tumors track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Pituitary Tumors. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Pituitary Tumors sessions?

Cancer researchers and clinicians, educators and students with an interest in Pituitary Tumors are all welcome — whether presenting or attending.

Can I present my research in the Pituitary Tumors track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Pituitary Tumors sessions?

Yes. CIOC 2027 is a hybrid conference — attend the Pituitary Tumors track in person in Singapore or join live online, with on-demand access afterward.

Join the CIOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us